Modeling the Impacts of Restrictive Formularies on Patients With HIV
Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.
The Option Value of Innovative Treatments in the Context of Chronic Myeloid Leukemia
Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis
This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.
